PUBLISHER: The Business Research Company | PRODUCT CODE: 1730977
PUBLISHER: The Business Research Company | PRODUCT CODE: 1730977
An over-the-counter test is a self-diagnostic medical test that individuals can buy without a prescription for personal use. It enables users to detect or monitor health conditions at home without the need for professional supervision. These tests offer quick and convenient results, supporting early detection and effective health management.
The primary product types of over-the-counter tests include glucose monitoring tests, pregnancy and fertility tests, coagulation monitoring tests, urinalysis tests, cholesterol tests, and other diagnostic tests. Glucose monitoring tests are devices used to measure blood sugar levels, helping individuals with diabetes track and manage their glucose levels. The technologies used in these tests include immunoassays, lateral flow assays, and dipsticks. These tests are utilized in various fields such as cardiology, oncology, glucose monitoring, pregnancy and fertility, infectious diseases, and toxicology, and are used by end-users such as hospitals, clinics, home care settings, diagnostic laboratories, and other healthcare facilities.
The over the counter test market research report is one of a series of new reports from The Business Research Company that provides over the counter test market statistics, including the over the counter test industry global market size, regional shares, competitors with the over the counter test market share, detailed over the counter test market segments, market trends, and opportunities, and any further data you may need to thrive in the over the counter test industry. This over the counter test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The over the counter test market size has grown rapidly in recent years. It will grow from $23.79 billion in 2024 to $27.20 billion in 2025 at a compound annual growth rate (CAGR) of 14.3%. The growth during the historic period can be attributed to factors such as the rise of smart home healthcare, increased remote patient monitoring, the growth of outpatient clinics, the expansion of mHealth (mobile health) solutions, and the growing popularity of subscription-based services.
The over the counter test market size is expected to see rapid growth in the next few years. It will grow to $46.11 billion in 2029 at a compound annual growth rate (CAGR) of 14.1%. The growth during the forecast period can be attributed to factors such as the increasing prevalence of infectious diseases, a rising number of HIV-infected individuals, greater use of remote patient monitoring, the growing penetration of smartphones, and the rise in healthcare-associated infections (HAIs). Key trends in the forecast period include the integration of digital health, connectivity with mobile apps, the adoption of integrated care models, the use of AI and machine learning, and remote infection control monitoring.
The increasing prevalence of chronic diseases is expected to drive the growth of the over-the-counter (OTC) test market. Chronic diseases are long-lasting conditions that persist for a year or more, often requiring continuous medical care or restricting daily activities. Factors such as unhealthy lifestyles, poor dietary habits, physical inactivity, and an aging population contribute to the rising prevalence of chronic conditions such as heart disease, diabetes, and obesity. OTC tests are vital for managing chronic diseases as they enable individuals to monitor their health regularly, detect potential issues early, and adjust treatment plans as necessary. For example, in June 2024, the Australian Institute of Health and Welfare reported that the death rate due to chronic conditions rose from 459 per 100,000 population in 2021 to 490 per 100,000 in 2022. This increasing prevalence of chronic diseases is driving the growth of the OTC test market.
Companies in the OTC test market are focusing on developing innovative non-invasive at-home diagnostics to improve accuracy, convenience, and early disease detection for self-monitoring. These diagnostics include medical tests and monitoring devices that enable individuals to assess their health conditions without invasive procedures. Technologies such as biosensors, saliva or urine tests, wearable devices, and imaging tools are used to measure vital signs, detect diseases, and monitor chronic conditions at home. For instance, in December 2023, DiaCarta Inc., a US-based molecular diagnostics company, launched the iColon test, an OTC at-home Fecal Occult Blood Test (FOBT) that received US FDA 510(k) clearance. This non-invasive test allows individuals to detect blood in their stool, a critical indicator of gastrointestinal disorders and colorectal cancer, in the comfort of their homes. The iColon test aims to improve early disease detection and encourage proactive health monitoring, leading to better patient outcomes.
In October 2024, Abhay HealthTech Private Limited, an India-based healthcare and technology company, acquired MNP Healthcare Private Limited for an undisclosed amount. This acquisition is intended to strengthen Abhay HealthTech's presence in the OTC healthcare segment by expanding its product range, manufacturing capabilities, and distribution network. MNP Healthcare is an India-based pharmaceutical company specializing in the production of blood glucose test kits.
Major players in the over the counter test market are Johnson & Johnson, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Viatris Inc., Roche Diagnostics Corporation, Hologic Inc., Nipro Diagnostics Inc., Quidel Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Everlywell Inc., LetsGetChecked Inc., OraSure Technologies Inc., Ellume Health Ltd., Bionime Corporation, ACON Laboratories Inc., Wondfo Biotech Co. Ltd., and Geratherm Medical AG.
North America was the largest region in the over-the-counter test market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in over the counter test report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the over the counter test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The over the counter test market consists of revenues earned by entities by providing services such as mobile app integration, subscription services, and follow-up lab testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The over the counter test market also includes sales of self-diagnostic medical test kits, home testing devices, rapid screening kits, point-of-care diagnostic tests, and at-home health monitoring kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Over The Counter Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on over the counter test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for over the counter test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The over the counter test market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.